Baxter International Inc
NYSE:BAX
Baxter International Inc
NYSE:BAX
Price:
34.09 USD
1.97%
Market Closed
Updated:
Jun 1, 2024
Baxter International Inc
Cash & Cash Equivalents
|
Baxter International Inc
Cash & Cash Equivalents Peer Comparison
Comparables:
BDX
BSX
SYK
ABT
ISRG
Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Baxter International Inc
NYSE:BAX
|
Cash & Cash Equivalents
$3B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
10%
|
CAGR 10-Years
4%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cash & Cash Equivalents
$2.3B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
28%
|
CAGR 10-Years
3%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash & Cash Equivalents
$2.3B
|
CAGR 3-Years
5%
|
CAGR 5-Years
76%
|
CAGR 10-Years
28%
|
|
|
Stryker Corp
NYSE:SYK
|
Cash & Cash Equivalents
$2.3B
|
CAGR 3-Years
1%
|
CAGR 5-Years
7%
|
CAGR 10-Years
5%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Cash & Cash Equivalents
$6.3B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
16%
|
CAGR 10-Years
12%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash & Cash Equivalents
$2.8B
|
CAGR 3-Years
27%
|
CAGR 5-Years
27%
|
CAGR 10-Years
13%
|
See Also
What is Baxter International Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
3B
USD
3B
USD
Based on the financial report for Mar 31, 2024, Baxter International Inc's Cash & Cash Equivalents amounts to 3B USD.
What is Baxter International Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
4%
4%
Over the last year, the Cash & Cash Equivalents growth was 81%. The average annual Cash & Cash Equivalents growth rates for Baxter International Inc have been -2% over the past three years , 10% over the past five years , and 4% over the past ten years .
You don't have any saved screeners yet
